Use of cannabinoids in the treatment of degenerative skeletal muscle disease

[thumbnail of Patent publication document]
Preview
Text (Patent publication document) - Published Version
· Please see our End User Agreement before downloading.
| Preview

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

GW PHARMA LTD (2016) Use of cannabinoids in the treatment of degenerative skeletal muscle disease. WO2016059411. doi: WO2016059411

Abstract/Summary

The present invention relates to the use of canninoids in the treatment of egenerative skeletal muscle disease. In particular the skeletal muscle disease is Duchenne muscular dystrophy

Altmetric Badge

Item Type Patent
URI https://reading-clone.eprints-hosting.org/id/eprint/77217
Identification Number/DOI WO2016059411
Divisions Life Sciences > School of Biological Sciences > Biomedical Sciences
Download/View statistics View download statistics for this item

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar